Novartis AG (NVS)
Novartis AG's stock hits a 52-week and all-time high, fueled by acquisition news and positive drug pricing outlooks, despite ongoing concerns about drug pricing and past legal issues.
About Novartis AG
Novartis AG is a global pharmaceutical company.
Novartis AG uses the ticker $NVS for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Novartis AG (NVS) social dominance is up 2266.62% from the previous week.
- Novartis AG Price hit a 52-Week high of $163.40 for the hour
- Novartis AG Price hit an all time of $163.40 for the hour
Price: $163.10
Price 24-Hour Time-Series Raw Data
The stock price has reached a 52-week and all-time high, driven by positive news regarding potential drug pricing deals and the acquisition of Avidity Biosciences, supported by strong social media engagement.
24-Hour: 0.58% 7-Day: 4.31% 30-Day: 13%
1-Year High: $163.10 on 2026-02-13
1-Year Low: $102 on 2025-04-08
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Novartis AG (NVS) is currently AltRank #578 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +110
[--] Months: [---] +120
[--] Year: [---] [----]
1-Year High: [-----] on 2025-06-30
1-Year Low: [--] on 2025-07-05
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +11
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-05-20
1-Year Low: [--] on 2025-07-28
Engagements: [-------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [-------]
[--] Week: [---------] -55%
[--] Month: [----------] +284%
[--] Months: [----------] +195%
[--] Year: [-----------] +175%
1-Year High: [---------] on 2025-11-28
1-Year Low: [------] on 2026-01-11
Engagements by network (24h): YouTube: [-------] X: [------] TikTok: [-----] Instagram: [---] Reddit: [---] News: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] -21%
[--] Month: [-----] +72%
[--] Months: [------] +32%
[--] Year: [------] +196%
1-Year High: [-----] on 2026-02-06
1-Year Low: [---] on 2025-07-01
Mentions by network (24h): YouTube: [---] X: [---] TikTok: [--] Instagram: [--] Reddit: [--] News: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Novartis AG (NVS) in the last [--] hours which is down 5.50% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [-----] -23%
[--] Month: [-----] +79%
[--] Months: [-----] +32%
[--] Year: [------] +166%
1-Year High: [---] on 2026-02-06
1-Year Low: [---] on 2025-07-01
The most influential creators that mention Novartis AG in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @novartis | [--] | [------] | [--] | [-------] |
| @novartis011 | [--] | [--] | [--] | [---] |
| @ArcaNovartis | [--] | [-----] | [--] | [---] |
| @tunemusicalmoments | [--] | [---------] | [--] | [---] |
| @FareedZakaria | [--] | [----------] | [--] | [---] |
| @StockMKTNewz | [--] | [-------] | [--] | [---] |
| @MasendeMbuzi | [--] | [---] | [--] | [---] |
| @narcoddict | [--] | [------] | [--] | [---] |
| @theboobiedocs | [--] | [------] | [--] | [---] |
| @NovartisUS | [--] | [-----] | [--] | [---] |
Sentiment: 91%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 91%
Daily Average: 86%
[--] Week: 87% -5%
[--] Month: 90% +11%
[--] Months: 90% +4%
[--] Year: 90% -6%
1-Year High: 98% on 2026-01-24
1-Year Low: 22% on 2025-08-26
Most Supportive Themes:
- WHO Partnership for Leprosy Elimination: (30%) Novartis AG's long-standing partnership with the WHO to provide free multidrug therapy for leprosy and support single-dose rifampicin.
- Acquisition of Avidity Biosciences: (30%) Novartis AG is acquiring Avidity Biosciences for $12 billion, aiming to strengthen its neuroscience pipeline.
- Pipeline Advancements: (20%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
- Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.
Most Critical Themes:
- Drug Pricing and Access Concerns: (60%) There are ongoing discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
- Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.
Social Dominance: 0.046%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.046%
Daily Average: 0.062%
[--] Week: 1.80% +1.70%
[--] Month: 0.065% +0.015%
[--] Months: 0.065% -0.0005000000000000004%
[--] Year: 0.065% +0.0086%
1-Year High: 0.143% on 2026-02-06
1-Year Low: 0.026% on 2025-07-01
Market Dominance: 0.353%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.353%
Daily Average: 0%
1-Year High: 8.30% on 2025-03-31
1-Year Low: 0.278% on 2025-10-29
Market Cap: $311,791,984,349
Market Cap 24-Hour Time-Series Raw Data
Current Value: $311,791,984,349
Daily Average: $241,293,465,599
[--] Week: $311,791,984,349 +4.60%
[--] Month: $311,219,538,845 +12%
[--] Months: $311,219,538,845 +26%
[--] Year: $311,219,538,845 +49%
1-Year High: $311,219,538,845 on 2026-02-13
1-Year Low: $201,380,099,726 on 2025-04-08
Top Novartis AG Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$NVO drops gender equality goals to satisfy MAGA USA (Roche and Novartis as well) Novo has changed its previous target of 45% female managers into a softer global aspiration a shift Danish media link to the current US political climate around DEI. The company says gender balance still matters but in [----] women held 44% of senior roles slightly below the original goal. Link to article: #StocksToWatch #investing https://medwatch.com/News/Pharma___Biotech/article19023609.ece https://medwatch.com/News/Pharma___Biotech/article19023609.ece"
X Link @investseekers 2026-02-16T18:28Z [----] followers, [---] engagements
"$ALT with novartis holding 8% of ALT wouldnt they be the leading secret investor to keep there ownership under 10% by using a proxy to increase shares Im not sure ive heard much about novartis being a good buyer for ALT any thoughts"
X Link @John_Porter10 2026-02-16T16:23Z [----] followers, [---] engagements
"@Newdawn234 @peace_igho Please dont come to south Africaits too bad here"
X Link @MasendeMbuzi 2026-02-16T16:03Z [---] followers, [---] engagements
"@alifarhat79 @ash1_par Abbott Pfizer GSK (GlaxoSmithKline) Sanofi and Novartis For decades thru their exorbitant loot prices the foreign pharma companies made people more poor in India than all Indian government health schemes brought them out of poverty"
X Link @rajprasha 2026-02-16T15:54Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing